Cycle Pharma
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · United Kingdom · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Broers Building, 21 J J Thomson Avenue, ...Phone Number
+44 1223354118Website
www.cyclepharma.comRevenue
$33.8 MillionIndustry
About Cycle Pharma
Cycle Pharmaceuticals is a UK-based pharmaceutical company focused on developing and commercializing treatments for patients with rare diseases, particularly in neurological, metabolic, and immunological areas. The company emphasizes improving existing therapies, repurposing drugs, and developing new formulations to enhance patient outcomes. With operations in both the UK and the United States, Cycle Pharmaceuticals provides not only medications but also patient support services, including nutritional guidance and assistance programs. The company aims to address unmet medical needs and improve quality of life for patients and caregivers dealing with rare and often genetic conditions.Explore more
Cycle Pharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Cycle Pharma
Compare insights from companies similar to Cycle Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Cycle Pharma Tech Stack
A closer look at the technologies used by Cycle Pharma
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cycle Pharma
Sign Up For FreeTo access detailed company insights
Cycle Pharmaceuticals is a UK-based pharmaceutical company focused on developing and commercializing treatments for patients with rare diseases, particularly in neurological, metabolic, and immunological areas. The company emphasizes improving existing therapies, repurposing drugs, and developing new formulations to enhance patient outcomes. With o... Read More
